source
- Safety concerns rise as Neurocrine's Prader-Willi drug linked to deaths and hospitalizationsPatient advocates and several experts are voicing increasing alarm over the safety profile of Neurocrine Biosciences' therapy for Prader-Willi syndrome. The drug, Vykat XR, received approval 18 mo…
- Insulet launches full U.S. release of Omnipod Discover data platform for Omnipod 5 usersInsulet announced that its Omnipod Discover platform is now fully available across the United States. The web-based service is built to work with the company’s Omnipod 5 automated insulin delivery…